🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 46185L103
- Market Cap
- Small Cap · $325 Million
- IPO
- 2/11/2015 · $16.00/share
Business: Invitae Corp. seeks to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Currently focused on hereditary cancers, Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time and lower price than many single-gene tests today. The company currently provides a single diagnostic test comprising over 200 genes for a variety of genetic disorders associated primarily with cancer, but also covering cardiology, hematology, neurology and pediatrics.
Company Contact
- CEO
- Sean Emerson George
- CFO
- Roxi Wen
- Headquarters
- 1400 16th Street, San Francisco San Francisco, CA 94103
- Phone
- 415-374-7782
- Investor Relations
- Laura D’Angelo · 628-213-3369 · ir@invitae.com